• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

晚期头颈部癌症根治性治疗后竞争非癌症死亡率的危险因素。

Risk factors for competing non-cancer mortality after definitive treatment for advanced-stage head and neck cancer.

机构信息

Department of Otolaryngology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

Department of Medicine (Oncology), Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

出版信息

Oral Dis. 2018 Oct;24(7):1217-1225. doi: 10.1111/odi.12904. Epub 2018 Jun 28.

DOI:10.1111/odi.12904
PMID:29804327
Abstract

OBJECTIVE

Patients with head and neck cancer (HNC) can die of index tumor progression and second tumor or non-cancer causes. Here, we investigated the risk factors for competing non-cancer mortality (NCM) in a prospective cohort of patients with advanced-stage HNC.

MATERIALS AND METHODS

A prospective observational study was conducted with 604 patients who underwent definitive treatment for advanced-stage HNC between 2010 and 2015. Main outcomes were NCM and cancer mortality (CM) defined as death from non-cancer causes and HNC or second cancers, respectively. Cumulative incidence and cause-specific hazard functions were used to analyze the risk factors of NCM and CM.

RESULTS

Age, smoking, Charlson comorbidity index (CCI), performance status, body mass index, rural residence, education and hemoglobin level at diagnosis, and chemotherapy were significantly associated with NCM (all p < 0.05). Multivariate analyses showed that age, CCI, and hemoglobin were independent factors of NCM. Age (≥65 years), CCI (≥2), and hemoglobin (<11 g/dl) were related to 4.5-, 3.2-, and 2.7-fold increased adjusted risk of NCM, respectively.

CONCLUSIONS

Old age, comorbidity, and hemoglobin at diagnosis were independent predictors of NCM. The risk factors could be used to predict non-cancer death after definitive treatment for advanced-stage HNC.

摘要

目的

头颈部癌症(HNC)患者可能因肿瘤进展和第二肿瘤或非癌症原因而死亡。在此,我们研究了前瞻性队列中晚期 HNC 患者发生竞争非癌症死亡率(NCM)的风险因素。

材料和方法

对 2010 年至 2015 年间接受晚期 HNC 确定性治疗的 604 例患者进行了前瞻性观察性研究。主要结局是 NCM 和癌症死亡率(CM),分别定义为非癌症原因和 HNC 或第二癌症导致的死亡。累积发生率和特定原因的危险函数用于分析 NCM 和 CM 的风险因素。

结果

年龄、吸烟、Charlson 合并症指数(CCI)、表现状态、体重指数、农村居住、教育和诊断时的血红蛋白水平以及化疗与 NCM 显著相关(均 p<0.05)。多变量分析显示,年龄、CCI 和血红蛋白是 NCM 的独立因素。年龄(≥65 岁)、CCI(≥2)和血红蛋白(<11 g/dl)与调整后的 NCM 风险分别增加 4.5、3.2 和 2.7 倍相关。

结论

年龄较大、合并症和诊断时的血红蛋白是 NCM 的独立预测因素。这些危险因素可用于预测晚期 HNC 确定性治疗后的非癌症死亡。

相似文献

1
Risk factors for competing non-cancer mortality after definitive treatment for advanced-stage head and neck cancer.晚期头颈部癌症根治性治疗后竞争非癌症死亡率的危险因素。
Oral Dis. 2018 Oct;24(7):1217-1225. doi: 10.1111/odi.12904. Epub 2018 Jun 28.
2
Noncancer health events as a leading cause of competing mortality in advanced head and neck cancer.非癌症健康事件是导致晚期头颈部癌症患者竞争死亡的主要原因。
Ann Oncol. 2014 Jun;25(6):1208-14. doi: 10.1093/annonc/mdu128. Epub 2014 Mar 25.
3
Comorbidity and prognosis in head and neck cancers: Differences by subsite, stage, and human papillomavirus status.头颈部癌症的合并症与预后:按亚部位、分期和人乳头瘤病毒状态划分的差异
Head Neck. 2014 Jun;36(6):802-10. doi: 10.1002/hed.23360. Epub 2013 Jul 30.
4
Cancer-specific mortality and competing mortality in patients with head and neck squamous cell carcinoma: a competing risk analysis.头颈部鳞状细胞癌患者的癌症特异性死亡率和竞争死亡率:一项竞争风险分析。
Ann Surg Oncol. 2015 Jan;22(1):264-71. doi: 10.1245/s10434-014-3951-8. Epub 2014 Jul 30.
5
Impact of comorbidity on outcome of young patients with head and neck squamous cell carcinoma.合并症对年轻头颈鳞状细胞癌患者预后的影响。
Head Neck. 1998 Jan;20(1):1-7. doi: 10.1002/(sici)1097-0347(199801)20:1<1::aid-hed1>3.0.co;2-8.
6
Population-based study of competing mortality in head and neck cancer.基于人群的头颈部癌症竞争死亡研究。
J Clin Oncol. 2011 Sep 10;29(26):3503-9. doi: 10.1200/JCO.2011.35.7301. Epub 2011 Aug 15.
7
Risk factors associated with competing mortality among patients with head and neck cancer in Japan.日本头颈癌患者中与竞争性死亡相关的危险因素。
Acta Otolaryngol. 2016;136(3):325-9. doi: 10.3109/00016489.2015.1117653. Epub 2015 Dec 4.
8
Undertreatment of women with locoregionally advanced head and neck cancer.局部晚期头颈部癌症女性患者的治疗不足。
Cancer. 2019 Sep 1;125(17):3033-3039. doi: 10.1002/cncr.32187. Epub 2019 May 15.
9
Effect of comorbidity on quality of life and treatment selection in patients with squamous cell carcinoma of the head and neck.合并症对头颈部鳞状细胞癌患者生活质量及治疗选择的影响
Laryngoscope. 2005 Aug;115(8):1371-5. doi: 10.1097/01.mlg.0000167983.32017.64.
10
Esophageal squamous cell neoplasia is an independent negative prognostic factor for head and neck cancer patients.食管鳞状细胞肿瘤是头颈部癌症患者独立的负性预后因素。
Int J Clin Oncol. 2018 Apr;23(2):243-248. doi: 10.1007/s10147-017-1201-3. Epub 2017 Oct 24.

引用本文的文献

1
Risk of early death after treatment with curative intent for head and neck squamous cell carcinoma: a retrospective population-based study.头颈部鳞状细胞癌根治性治疗后的早期死亡风险:一项基于人群的回顾性研究。
Acta Oncol. 2025 Mar 4;64:339-348. doi: 10.2340/1651-226X.2025.42202.
2
Long-term Survivorship and Non-cancer Competing Mortality in Head and Neck Cancer: A Nationwide Population-Based Study in South Korea.头颈部癌症的长期生存和非癌症竞争死亡率:韩国全国人群研究。
Cancer Res Treat. 2023 Jan;55(1):50-60. doi: 10.4143/crt.2021.1086. Epub 2022 Mar 4.
3
In-Hospital and Long-Term Outcomes in Patients with Head and Neck Cancer Bleeding.
头颈部癌症出血患者的住院期间和长期预后。
Medicina (Kaunas). 2022 Jan 25;58(2):177. doi: 10.3390/medicina58020177.
4
Development of a competing risk nomogram for the prediction of cause-specific mortality in patients with thymoma: a population-based analysis.胸腺瘤患者特定病因死亡率预测的竞争风险列线图的开发:一项基于人群的分析
J Thorac Dis. 2021 Dec;13(12):6838-6847. doi: 10.21037/jtd-21-931.
5
Factors to consider for surgical in elderly patients with oral cancer.老年口腔癌患者手术治疗的考虑因素
J Korean Assoc Oral Maxillofac Surg. 2021 Oct 31;47(5):388-393. doi: 10.5125/jkaoms.2021.47.5.388.
6
Association between comorbidity and survival in head and neck cancer: Results from Head and Neck 5000.头颈部肿瘤中合并症与生存的关系:来自头颈部 5000 研究的结果。
Head Neck. 2019 Apr;41(4):1053-1062. doi: 10.1002/hed.25543. Epub 2018 Dec 14.